Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000615745> ?p ?o ?g. }
- W2000615745 endingPage "1339" @default.
- W2000615745 startingPage "1329" @default.
- W2000615745 abstract "The induction of strong cell-mediated immunity against targeted cancer cells is difficult, and often requires specific vaccination schema and the appropriate adjuvants to be effective. The chemokine RANTES has been studied as a vaccine adjuvant in cancer therapy, but specific applications remain to be determined. For gene-based vaccination against B16 melanoma in C57BL/6JNarl mice, initial priming with mouse RANTES cDNA followed 24 h later by human gp100 DNA vaccination, and later boosting with a viral vector expressing mRANTES and hgp100 strongly suppressed B16/hgp100 primary tumors and lung metastasis. The inclusion of mRANTES in this vaccination regimen gave significantly better suppression of tumor growth, substantially enhanced mouse survival, and led to greater cytotoxic activity of splenocytes against B16/hgp100 cells than vaccination against hgp100 alone. B16/hgp100 melanoma cells were resistant to the ligands TRAIL and FasL in vitro but sensitized to them in vivo owing to the priming effect of cytokines in response to vaccination. Our data demonstrate that co-vaccination with chemokine (mRANTES) and tumor-specific (hgp100) genes in a specific time sequence is more effective at suppressing tumor growth and metastasis than hgp100 alone, and this effect may be mediated by sensitization of tumor cells to death ligands." @default.
- W2000615745 created "2016-06-24" @default.
- W2000615745 creator A5017373010 @default.
- W2000615745 creator A5018742816 @default.
- W2000615745 creator A5019896192 @default.
- W2000615745 creator A5021013668 @default.
- W2000615745 creator A5043313965 @default.
- W2000615745 creator A5062826651 @default.
- W2000615745 creator A5068186967 @default.
- W2000615745 creator A5070494006 @default.
- W2000615745 date "2009-07-23" @default.
- W2000615745 modified "2023-09-27" @default.
- W2000615745 title "Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma" @default.
- W2000615745 cites W1508110130 @default.
- W2000615745 cites W1528349069 @default.
- W2000615745 cites W1534766853 @default.
- W2000615745 cites W1596576376 @default.
- W2000615745 cites W1601402644 @default.
- W2000615745 cites W1613950543 @default.
- W2000615745 cites W1751960924 @default.
- W2000615745 cites W1788104986 @default.
- W2000615745 cites W1790202563 @default.
- W2000615745 cites W1972340205 @default.
- W2000615745 cites W1977408485 @default.
- W2000615745 cites W1986046751 @default.
- W2000615745 cites W1995172530 @default.
- W2000615745 cites W1996391900 @default.
- W2000615745 cites W2001913065 @default.
- W2000615745 cites W2005238233 @default.
- W2000615745 cites W2014179113 @default.
- W2000615745 cites W2014392976 @default.
- W2000615745 cites W2017873264 @default.
- W2000615745 cites W2019801925 @default.
- W2000615745 cites W2020228079 @default.
- W2000615745 cites W2028474769 @default.
- W2000615745 cites W2030448367 @default.
- W2000615745 cites W2035098893 @default.
- W2000615745 cites W2039825042 @default.
- W2000615745 cites W2049160937 @default.
- W2000615745 cites W2062096354 @default.
- W2000615745 cites W2071150424 @default.
- W2000615745 cites W2085036470 @default.
- W2000615745 cites W2087568024 @default.
- W2000615745 cites W2092768308 @default.
- W2000615745 cites W2093705034 @default.
- W2000615745 cites W2095135796 @default.
- W2000615745 cites W2095363203 @default.
- W2000615745 cites W2106469410 @default.
- W2000615745 cites W2107001200 @default.
- W2000615745 cites W2118526748 @default.
- W2000615745 cites W2125580285 @default.
- W2000615745 cites W2136368623 @default.
- W2000615745 cites W2142501626 @default.
- W2000615745 cites W2146600597 @default.
- W2000615745 cites W2153746213 @default.
- W2000615745 cites W2156852213 @default.
- W2000615745 cites W2310081349 @default.
- W2000615745 doi "https://doi.org/10.1038/gt.2009.90" @default.
- W2000615745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19626052" @default.
- W2000615745 hasPublicationYear "2009" @default.
- W2000615745 type Work @default.
- W2000615745 sameAs 2000615745 @default.
- W2000615745 citedByCount "19" @default.
- W2000615745 countsByYear W20006157452012 @default.
- W2000615745 countsByYear W20006157452013 @default.
- W2000615745 countsByYear W20006157452014 @default.
- W2000615745 countsByYear W20006157452016 @default.
- W2000615745 countsByYear W20006157452017 @default.
- W2000615745 countsByYear W20006157452018 @default.
- W2000615745 countsByYear W20006157452020 @default.
- W2000615745 countsByYear W20006157452023 @default.
- W2000615745 crossrefType "journal-article" @default.
- W2000615745 hasAuthorship W2000615745A5017373010 @default.
- W2000615745 hasAuthorship W2000615745A5018742816 @default.
- W2000615745 hasAuthorship W2000615745A5019896192 @default.
- W2000615745 hasAuthorship W2000615745A5021013668 @default.
- W2000615745 hasAuthorship W2000615745A5043313965 @default.
- W2000615745 hasAuthorship W2000615745A5062826651 @default.
- W2000615745 hasAuthorship W2000615745A5068186967 @default.
- W2000615745 hasAuthorship W2000615745A5070494006 @default.
- W2000615745 hasBestOaLocation W20006157451 @default.
- W2000615745 hasConcept C100701293 @default.
- W2000615745 hasConcept C13373296 @default.
- W2000615745 hasConcept C154317977 @default.
- W2000615745 hasConcept C159047783 @default.
- W2000615745 hasConcept C167508917 @default.
- W2000615745 hasConcept C202751555 @default.
- W2000615745 hasConcept C203014093 @default.
- W2000615745 hasConcept C22070199 @default.
- W2000615745 hasConcept C2777658100 @default.
- W2000615745 hasConcept C2777701055 @default.
- W2000615745 hasConcept C2777863537 @default.
- W2000615745 hasConcept C2778378633 @default.
- W2000615745 hasConcept C2780801004 @default.
- W2000615745 hasConcept C502942594 @default.
- W2000615745 hasConcept C55493867 @default.
- W2000615745 hasConcept C59822182 @default.
- W2000615745 hasConcept C81444415 @default.